The Down syndrome brain in the presence and absence of fibrillar β-amyloidosis

Por Annus, Tiina, Wilson, Liam R., Acosta-Cabronero, Julio, Cardenas-Blanco, Arturo, Hong, Young T., Fryer, Tim D., Coles, Jonathan P., Menon, David K., Zaman, Shahid H., Holland, Anthony J., Nestor, Peter J.
Publicado no Neurobiol Aging (2017)

Brain-predicted age in Down syndrome is associated with beta amyloid deposition and cognitive decline

Por Cole, James H., Annus, Tiina, Wilson, Liam R., Remtulla, Ridhaa, Hong, Young T., Fryer, Tim D., Acosta-Cabronero, Julio, Cardenas-Blanco, Arturo, Smith, Robert, Menon, David K., Zaman, Shahid H., Nestor, Peter J., Holland, Anthony J.
Publicado no Neurobiol Aging (2017)

Erythromyeloid-Derived TREM2: A Major Determinant of Alzheimer’s Disease Pathology in Down Syndrome

Por Raha-Chowdhury, Ruma, Henderson, James W., Raha, Animesh Alexander, Stott, Simon R.W., Vuono, Romina, Foscarin, Simona, Wilson, Liam, Annus, Tiina, Fincham, Robert, Allinson, Kieren, Devalia, Vinod, Friedland, Robert P., Holland, Anthony, Zaman, Shahid H.
Publicado no J Alzheimers Dis (2018)

The pattern of amyloid accumulation in the brains of adults with Down syndrome

Por Annus, Tiina, Wilson, Liam R., Hong, Young T., Acosta–Cabronero, Julio, Fryer, Tim D., Cardenas–Blanco, Arturo, Smith, Robert, Boros, Istvan, Coles, Jonathan P., Aigbirhio, Franklin I., Menon, David K., Zaman, Shahid H., Nestor, Peter J., Holland, Anthony J.
Publicado no Alzheimers Dement (2016)